Allianz Biosciences Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
- Paid Up Capital ₹ 5.50 M
- Company Age 22 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.90 Cr
- Revenue Growth 30.23%
- Profit Growth 45.64%
- Ebitda 58.31%
- Net Worth 0.85%
- Total Assets -0.95%
About Allianz Biosciences
Allianz Biosciences Private Limited (ABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 January 2003 and has a history of 22 years. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Healkraft Remedies (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 5.50 M.
The company currently has active open charges totaling ₹4.90 Cr.
Srinivasan Balamurugan and Murugesan Kumar serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231TN2003PTC050203
-
Company No.
050203
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jan 2003
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Allianz Biosciences Private Limited offer?
Allianz Biosciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Fitness Supplements, L-Valine, Digestive System Drugs & Medicines, Antacid Drugs, Pharmaceutical Medicine, Pain Killers, Forte Tablets.
Who are the key members and board of directors at Allianz Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasan Balamurugan
|
Director | 23-Oct-2019 | Current |
|
Murugesan Kumar
|
Whole-Time Director | 08-Jul-2009 | Current |
Financial Performance of Allianz Biosciences.
Allianz Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.23% increase. The company also saw a substantial improvement in profitability, with a 45.64% increase in profit. The company's net worth moved up by a moderate rise of 0.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allianz Biosciences?
In 2022, Allianz Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹49.00 M
₹0
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 4.80 Cr
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Feb 2020 | State Bank Of India | ₹1.00 M | Open |
| 20 Jul 2011 | Citi Bank N.A. | ₹4.80 Cr | Open |
How Many Employees Work at Allianz Biosciences?
Allianz Biosciences has a workforce of 123 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allianz Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allianz Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
